BD to Present at Barclays Capital 2010 Healthcare Conference

Tuesday, March 16, 2010 General News J E 4

FRANKLIN LAKES, N.J., March 15 BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that the Company will present at the Barclays Capital 2010 Healthcare Conference on Wednesday, March 24, 2010 at 11:15 a.m. (EDT).

The live webcast of BD's presentation can be accessed at the BD corporate website at and will be available for replay through Wednesday, March 31, 2010.

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit

Contact: -------- Sherry L. Bertner, Investor Relations - 201-847-5453 Colleen T. White, Corporate Communications - 201-847-5369

SOURCE BD (Becton, Dickinson and Company)


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
CT Corsearch Announces Trademark Search Capabiliti...
NGM Biopharmaceuticals Raises $51 Million in Serie...